Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Pulmonary Hypertension, January 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 220 articles:
HTML format


 

Single Articles

  1. BARNETT CF, O'Brien C, De Marco T
    Critical care management of the patient with pulmonary hypertension.
    Eur Heart J Acute Cardiovasc Care. 2021 Dec 30. pii: 6489691.
    PubMed    
    Abstract available

  2. ZHANG X, Zhang C, Li Q, Piao C, et al
    Clinical characteristics and prognosis analysis of idiopathic and hereditary pulmonary hypertension patients with ACVRL1 gene mutations.
    Pulm Circ. 2021;11:20458940211044577.
    PubMed    
    Abstract available

  3. MIAO R, Dong X, Gong J, Li Y, et al
    Examining the Development of Chronic Thromboembolic Pulmonary Hypertension at the Single-Cell Level.
    Hypertension. 2021 Dec 30:HYPERTENSIONAHA12118105.
    PubMed    
    Abstract available

  4. WANG P, Chen X, Zhang J, Ma Y, et al
    Continuous epidural anesthesia with double catheters for cesarean section in a patient with severe pulmonary hypertension: A case report.
    Medicine (Baltimore). 2021;100:e27979.
    PubMed    
    Abstract available

  5. JIANG H, Niu Y, He Y, Li X, et al
    Proteomic analysis reveals that Xbp1s promotes hypoxic pulmonary hypertension through the p-JNK MAPK pathway.
    J Cell Physiol. 2021 Dec 28. doi: 10.1002/jcp.30664.
    PubMed    
    Abstract available

  6. JIAO HX, Yuan SX, Huang YZ, Su QW, et al
    [TRPV4 channel mediates the increase of pulmonary microvascular endothelial permeability in rats with chronic hypoxic pulmonary hypertension].
    Sheng Li Xue Bao. 2021;73:867-877.
    PubMed    
    Abstract available

  7. ZHAO QH, Gong SG, He J, Yuan P, et al
    Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial.
    Trials. 2021;22:957.
    PubMed    
    Abstract available

  8. WIETESKA-MILEK M, Szmit S, Florczyk M, Kusmierczyk-Droszcz B, et al
    COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination.
    Vaccines (Basel). 2021;9.
    PubMed    
    Abstract available

  9. PENG H, Zhou L, Li H, Zhang Y, et al
    The therapeutic effect and mechanism of Rapamycin combined with HO-3867 on monocrotaline-induced pulmonary hypertension in rats.
    Eur J Pharm Sci. 2021 Dec 24:106102. doi: 10.1016/j.ejps.2021.106102.
    PubMed    
    Abstract available

  10. MEHTA V, Chaudhari D, Mehra P, Mahajan S, et al
    Left Atrial Function by Two-Dimensional Speckle Tracking Echocardiography in Patients with Severe Rheumatic Mitral Stenosis and Pulmonary Hypertension.
    Indian Heart J. 2021 Dec 24. pii: S0019-4832(21)00462.
    PubMed    
    Abstract available

  11. DE BIE FR, Avitabile CM, Joyeux L, Hedrick HL, et al
    Neonatal and fetal therapy of congenital diaphragmatic hernia-related pulmonary hypertension.
    Arch Dis Child Fetal Neonatal Ed. 2021 Dec 24. pii: archdischild-2021-322617.
    PubMed    
    Abstract available

  12. C S, Kundana PK, Reddy N, Reddy B S, et al
    Thiamine-responsive, life-threatening, pulmonary hypertensive crisis with encephalopathy in young infants: A case series.
    Eur J Paediatr Neurol. 2021;36:93-98.
    PubMed    
    Abstract available

  13. HANNEMANN J, Siques P, Schmidt-Hutten L, Zummack J, et al
    Association of Genes of the NO Pathway with Altitude Disease and Hypoxic Pulmonary Hypertension.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  14. NIE X, Shen C, Tan J, Yang X, et al
    Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling.
    Biomolecules. 2021;11.
    PubMed    
    Abstract available

  15. ROGER I, Milara J, Belhadj N, Cortijo J, et al
    Senescence Alterations in Pulmonary Hypertension.
    Cells. 2021;10.
    PubMed    
    Abstract available

  16. ELSAIE A, Menon RT, Shrestha AK, Gowda SH, et al
    Endothelial Adenosine Monophosphate-Activated Protein Kinase-Alpha1 Deficiency Potentiates Hyperoxia-Induced Experimental Bronchopulmonary Dysplasia and Pulmonary Hypertension.
    Antioxidants (Basel). 2021;10.
    PubMed    
    Abstract available

  17. KORKMAZ S, Akbulut M, Kazgan A, Hekim A, et al
    Suicidal Ideation, Self-esteem, and Hopelessness in Patients With Pulmonary Arterial Hypertension.
    Prim Care Companion CNS Disord. 2021;23.
    PubMed    
    Abstract available

  18. PERROS F, Humbert M, Dorfmuller P
    Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension.
    Eur Respir Rev. 2021;30.
    PubMed    
    Abstract available

  19. KARIOTIS S, Jammeh E, Swietlik EM, Pickworth JA, et al
    Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood.
    Nat Commun. 2021;12:7104.
    PubMed    
    Abstract available

  20. THOREAU B, Chaigne B, Renaud A, Mouthon L, et al
    Treatment of systemic sclerosis.
    Presse Med. 2021;50:104088.
    PubMed    
    Abstract available

  21. SCHUSSLER A, Tello K, Roller FC, Krombach GA, et al

    Rofo. 2022;194:90-92.
    PubMed    


  22. BERNAL-RAMIREZ J, Silva-Platas C, Jerjes-Sanchez C, Ramos-Gonzalez MR, et al
    Resveratrol Prevents Right Ventricle Dysfunction, Calcium Mishandling, and Energetic Failure via SIRT3 Stimulation in Pulmonary Arterial Hypertension.
    Oxid Med Cell Longev. 2021;2021:9912434.
    PubMed    
    Abstract available

  23. BARRERA-CHIMAL J, Jaisser F
    MR (Mineralocorticoid Receptor) in Endothelial Cells: A Major Contributor in Pulmonary Arterial Hypertension Remodeling.
    Hypertension. 2021;78:466-468.
    PubMed    


  24. SATYAMURTHY A, Padmakumar R, Babu AS
    Exercise-Based Cardiopulmonary Rehabilitation for Pulmonary Arterial Hypertension as a Therapeutic Option in Low- and Middle-Income Countries.
    Can J Cardiol. 2021;37:1685-1686.
    PubMed    


  25. YASUI K, Yuda S, Abe K, Asanuma K, et al
    Prognostic value of 6-min walk stress echocardiography in patients with interstitial lung disease.
    J Echocardiogr. 2021;19:232-242.
    PubMed    
    Abstract available

  26. SHARMA A, Sood BG, Qureshi F, Xin Y, et al
    Chronic Inflammatory Placental Lesions Correlate With Bronchopulmonary Dysplasia Severity in Extremely Preterm Infants.
    Pediatr Dev Pathol. 2021;24:430-437.
    PubMed    
    Abstract available

  27. LECHARTIER B, Humbert M
    Pulmonary arterial hypertension in systemic sclerosis.
    Presse Med. 2021;50:104062.
    PubMed    
    Abstract available

  28. CHEN HH, Lin CH, Hsieh TY, Chen DY, et al
    Factors associated with incident severe pulmonary arterial hypertension in systemic autoimmune rheumatic diseases: a nationwide study.
    Rheumatology (Oxford). 2021;60:5351-5361.
    PubMed    
    Abstract available

  29. GRAZIOLI V, Ghio S, Pin M, Sciortino A, et al
    Pulmonary endarterectomy in the octogenarian population: safety and outcomes.
    J Cardiovasc Med (Hagerstown). 2021;22:567-571.
    PubMed    
    Abstract available

  30. SATHANANTHAN G, Levy RD, Swiston J, Brunner NW, et al
    Evolving Paradigms in the Treatment of Atrial Septal Defects With Pulmonary Arterial Hypertension.
    Cardiol Rev. 2021;29:305-309.
    PubMed    
    Abstract available

  31. KOBAYASHI M, Gargani L, Palazzuoli A, Ambrosio G, et al
    Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure: findings from a pooled analysis of four cohort studies.
    Clin Res Cardiol. 2021;110:1181-1192.
    PubMed    
    Abstract available

  32. BOUZINA H, Hesselstrand R, Radegran G
    Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension.
    Scand Cardiovasc J. 2021;55:35-42.
    PubMed    
    Abstract available

  33. DAL COL AK, Bhombal S, Tacy TA, Hintz SR, et al
    Comprehensive Echocardiographic Assessment of Ventricular Function and Pulmonary Pressure in the Neonatal Omphalocele Population.
    Am J Perinatol. 2021;38.
    PubMed    
    Abstract available

  34. GOVETTO A, Sarraf D, Scialdone A
    "HIDE AND SEEK" NEUROSENSORY RETINAL DETACHMENTS IN PERIPAPILLARY PACHYCHOROID SYNDROME ASSOCIATED WITH PULMONARY ARTERIAL HYPERTENSION.
    Retin Cases Brief Rep. 2022;16:118-125.
    PubMed    
    Abstract available

  35. ELAMAA H, Kaakinen M, Natynki M, Szabo Z, et al
    PHD2 deletion in endothelial or arterial smooth muscle cells reveals vascular cell type-specific responses in pulmonary hypertension and fibrosis.
    Angiogenesis. 2022 Jan 8. pii: 10.1007/s10456-021-09828.
    PubMed    
    Abstract available

  36. BURGER CD
    In reply-Exercise-Based Cardiopulmonary Rehabilitation: A Suitable Addition to Pharmacological Therapy for Pulmonary Hypertension.
    Mayo Clin Proc. 2022;97:191-192.
    PubMed    


  37. SHAH S, Poojary G, Babu AS
    Exercise-Based Cardiopulmonary Rehabilitation: A Suitable Addition to Pharmacological Therapy for Pulmonary Hypertension.
    Mayo Clin Proc. 2022;97:190-191.
    PubMed    


  38. WANG H, Chen RB, Zhang SN, Zhang RF, et al
    N7-methylguanosine modification of lncRNAs in a rat model of hypoxic pulmonary hypertension: a comprehensive analysis.
    BMC Genomics. 2022;23:33.
    PubMed    
    Abstract available

  39. SIMONSON JL, Pandya D, Khan S, Verma S, et al
    Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension.
    Sleep Breath. 2022 Jan 7. pii: 10.1007/s11325-021-02555.
    PubMed    
    Abstract available

  40. VOS JL, Leiner T, van Dijk APJ, Pedrizzetti G, et al
    Cardiovascular magnetic resonance-derived left ventricular intraventricular pressure gradients among patients with precapillary pulmonary hypertension.
    Eur Heart J Cardiovasc Imaging. 2022 Jan 5. pii: 6498031.
    PubMed    
    Abstract available

  41. MAEDER MT, Weber L, Seidl S, Weilenmann D, et al
    Wedge Pressure vs Left Ventricular End-Diastolic Pressure for Pulmonary Hypertension Classification and Prognostication in Severe Aortic Stenosis.
    CJC Open. 2021;3:1428-1437.
    PubMed    
    Abstract available

  42. HWALEK A, Rosenheck JP, Whitson BA
    Lung transplantation for pulmonary hypertension.
    J Thorac Dis. 2021;13:6708-6716.
    PubMed    
    Abstract available

  43. NAGARAJU SP, Bhojaraja MV, Paramasivam G, Prabhu RA, et al
    Risk Factors of Pulmonary Hypertension in Patients on Hemodialysis: A Single Center Study.
    Int J Nephrol Renovasc Dis. 2021;14:487-494.
    PubMed    
    Abstract available

  44. ADNAN M, Arshad MS, Anwar-Ul-Haq HM, Ahmad M, et al
    Persistent Pulmonary Hypertension of the Newborn: The Efficacy Comparison of Vasodilators Sildenafil Plus Bosentan Versus Sildenafil Plus Beraprost at a Tertiary Childcare Health Facility.
    Cureus. 2021;13:e20020.
    PubMed    
    Abstract available

  45. KLINGER JR, Pereira M, Tatto MD, Dooner MS, et al
    Effect of dose, dosing intervals, and hypoxic stress on the reversal of pulmonary hypertension by mesenchymal stem cell extracellular vesicles.
    Pulm Circ. 2021;11:20458940211046137.
    PubMed    
    Abstract available

  46. CAO R, Sun T, Xu R, Zheng J, et al
    Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels.
    Front Pharmacol. 2021;12:764046.
    PubMed    
    Abstract available

  47. OKBAY GUNES A, Ciftel M, Timur ME, Dedebali C, et al
    Efficacy and safety of endotracheal instillation of iloprost for persistent pulmonary hypertension of the newborn.
    Cardiol Young. 2022 Jan 6:1-7. doi: 10.1017/S1047951121005072.
    PubMed    
    Abstract available

  48. CHAN WL, Lin CC, Wei JC
    Pulmonary hypertension is associated with an increased incidence of NAFLD.
    J Intern Med. 2022 Jan 4. doi: 10.1111/joim.13415.
    PubMed    


  49. JORDENS MS, Luedde M, Roderburg C, Demir M, et al
    Authors' reply: Pulmonary hypertension is associated with an increased incidence of NAFLD.
    J Intern Med. 2022 Jan 4. doi: 10.1111/joim.13414.
    PubMed    


  50. AMIN F, Yousefvand S, Jamialahmadi T, Johnston TP, et al
    Protective Effects of Curcumin on Pulmonary Arterial Hypertension.
    Adv Exp Med Biol. 2021;1328:213-221.
    PubMed    
    Abstract available

  51. XIONG PY, Motamed M, Chen KH, Dasgupta A, et al
    Inhibiting Pyruvate Kinase Muscle Isoform 2 Regresses Group 2 Pulmonary Hypertension Induced by Supra-coronary Aortic Banding.
    Acta Physiol (Oxf). 2022 Jan 3:e13764. doi: 10.1111/apha.13764.
    PubMed    
    Abstract available

  52. OHSUMI A, Aoyama A, Kinoshita H, Yoneda T, et al
    New strategy to resume and taper epoprostenol after lung transplant for pulmonary hypertension.
    Gen Thorac Cardiovasc Surg. 2022 Jan 3. pii: 10.1007/s11748-021-01746.
    PubMed    
    Abstract available

  53. YAN Y, Jiang R, Yuan P, Wen L, et al
    Implication of proliferation gene biomarkers in pulmonary hypertension.
    Animal Model Exp Med. 2021;4:369-380.
    PubMed    
    Abstract available

  54. YUN X, Philip NM, Jiang H, Smith Z, et al
    Upregulation of Aquaporin 1 Mediates Increased Migration and Proliferation in Pulmonary Vascular Cells From the Rat SU5416/Hypoxia Model of Pulmonary Hypertension.
    Front Physiol. 2021;12:763444.
    PubMed    
    Abstract available

  55. HE YY, Xie XM, Zhang HD, Ye J, et al
    Corrigendum: Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension.
    Front Pharmacol. 2021;12:810178.
    PubMed    
    Abstract available

  56. JARIWALA P, Maturu VN, Jadhav KP, Punjani A, et al
    The clinical experience of macitentan in pulmonary hypertension in Indian cohort: 12-month follow-up.
    Lung India. 2022;39:12-15.
    PubMed    
    Abstract available

  57. PERVAIZ A, Saydain G
    Pulmonary hypertension in India: Need for organized approach.
    Lung India. 2022;39:3-4.
    PubMed    


  58. YANG X, Zhang L, Ye JQ, Wu XH, et al
    Retraction notice to "The role of ATG-7 contributes to pulmonary hypertension by impacting vascular remodeling" [Journal of Molecular and Cellular Cardiology 157C (2021) 1-13].
    J Mol Cell Cardiol. 2021 Dec 29. pii: S0022-2828(21)00229.
    PubMed    


  59. KONG F, Sun YL, Yuan B
    Prevalence of pulmonary hypertension in children with adenoid or adenotonsillar hypertrophy: A meta-analysis.
    Int J Pediatr Otorhinolaryngol. 2021;153:111019.
    PubMed    
    Abstract available

  60. EL-BOKL A, Jimenez E, Hiremath G, Cortez D, et al
    Is derived vectorcardiography a potential screening tool for pulmonary hypertension?
    J Electrocardiol. 2021;70:79-83.
    PubMed    
    Abstract available

  61. DE BARROS JA, Sant'Ana G, Martins G, Madlum L, et al
    Severity of precapillary pulmonary hypertension: Predictive factor.
    Pulmonology. 2021 Dec 28. pii: S2531-0437(21)00226.
    PubMed    
    Abstract available

  62. LLUCIA-VALLDEPERAS A, Smal R, Bekedam FT, Ce M, et al
    Development of a 3-Dimensional Model to Study Right Heart Dysfunction in Pulmonary Arterial Hypertension: First Observations.
    Cells. 2021;10.
    PubMed    
    Abstract available

  63. PEWOWARUK RJ, Forouzan O, Raza F, Gepner AD, et al
    Non-invasive estimation of pulmonary hemodynamics from 2D-PC MRI with an arterial mechanics method.
    J Biomech. 2021;129:110856.
    PubMed    
    Abstract available

  64. MARTINEZ-GONZALEZ J, Canes L, Alonso J, Ballester-Servera C, et al
    NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available


  65. Pulmonary arterial hypertension: An overview.
    Nursing. 2021;51:43-44.
    PubMed    


  66. JOHNSON S, Gordeuk VR, Machado R, Gibbs JSR, et al
    Exercise-induced changes of vital signs in adults with sickle cell disease.
    Am J Hematol. 2021;96:1630-1638.
    PubMed    
    Abstract available

  67. VAN DE BOVENKAMP AA, Enait V, de Man FS, Oosterveer FTP, et al
    Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction.
    J Am Heart Assoc. 2021;10:e021165.
    PubMed    
    Abstract available

  68. DOU X, Ma Y, Qin Y, Dong Q, et al
    NEAT1 silencing alleviates pulmonary arterial smooth muscle cell migration and proliferation under hypoxia through regulation of miR34a5p/KLF4 in vitro.
    Mol Med Rep. 2021;24.
    PubMed    
    Abstract available

  69. KAROLAK JA, Gambin T, Szafranski P, Maywald RL, et al
    Perturbation of semaphorin and VEGF signaling in ACDMPV lungs due to FOXF1 deficiency.
    Respir Res. 2021;22:212.
    PubMed    
    Abstract available

  70. NAPLES R, Ramaiah S, Rankin J, Berrington J, et al
    Life-threatening bronchopulmonary dysplasia: a British Paediatric Surveillance Unit Study.
    Arch Dis Child Fetal Neonatal Ed. 2022;107:13-19.
    PubMed    
    Abstract available

  71. TANAKA S, Imamura T, Narang N, Fukuda N, et al
    Practical Therapeutic Management of Percutaneous Atrial Septal Defect Closure.
    Intern Med. 2022;61:15-22.
    PubMed    
    Abstract available

  72. GRIGNOLA JC, Trujillo P
    Proximal pulmonary arterial remodeling impairs right ventricular-arterial coupling in postcapillary pulmonary hypertension patients.
    J Appl Physiol (1985). 2022;132:217-218.
    PubMed    


  73. SASIPRAPHA T, Pussadhamma B, Sibmooh N, Sriwantana T, et al
    Efficacy and safety of inhaled nitrite in addition to sildenafil in thalassemia patients with pulmonary hypertension: A 12-week randomized, double-blind placebo-controlled clinical trial.
    Nitric Oxide. 2022 Jan 10. pii: S1089-8603(21)00137.
    PubMed    
    Abstract available

  74. AHMED S, Ahmed A, Radegran G
    Data on plasma tumour and metabolism related proteins' potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension.
    Data Brief. 2021;40:107747.
    PubMed    
    Abstract available

  75. DOCTOR P, Blake J, Aggarwal S
    Role of sildenafil in a neonate with double outlet left ventricle and pulmonary hypertension.
    J Cardiol Cases. 2021;25:46-48.
    PubMed    
    Abstract available

  76. SABOE A, Marindani V, Cool CJ, Syawaluddin H, et al
    A Case of Complex Pulmonary Hypertension: the Importance of Diagnostic Investigation.
    Clin Med Insights Circ Respir Pulm Med. 2022;16:11795484211073292.
    PubMed    
    Abstract available

  77. KUBOTA K, Imai Y, Oh I, Ueno S, et al
    Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose.
    Intern Med. 2022 Jan 13. doi: 10.2169/internalmedicine.8392.
    PubMed    
    Abstract available

  78. CHIBA Y, Iwano H, Tsuneta S, Tsujinaga S, et al
    Determinants of altered left ventricular suction in pre-capillary pulmonary hypertension.
    Eur Heart J Cardiovasc Imaging. 2022 Jan 10. pii: 6501543.
    PubMed    
    Abstract available

  79. CAJIGAS HR, Kaptzan T, Lewis B, El-Sabbagh A, et al
    The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30057.
    PubMed    
    Abstract available

  80. COSKUN FY, Taysi S, Kayikcioglu M
    Can serum 8-hydroxy-2'-deoxyguanosine levels reflect the severity of pulmonary arterial hypertension?
    Rev Assoc Med Bras (1992). 2021;67:1437-1442.
    PubMed    
    Abstract available

  81. PELS A, Onland W, Berger RMF, van Heijst AFJ, et al
    Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the Dutch STRIDER study.
    Eur J Pediatr. 2022 Jan 12. pii: 10.1007/s00431-021-04355.
    PubMed    
    Abstract available

  82. GUO M, Zhang M, Cao X, Fang X, et al
    Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.
    Respir Res. 2022;23:6.
    PubMed    
    Abstract available

  83. JAROSZYNSKI A, Schlegel TT, Zaborowski T, Zapolski T, et al
    The value of ventricular gradient for predicting pulmonary hypertension and mortality in hemodialysis patients.
    Sci Rep. 2022;12:456.
    PubMed    
    Abstract available

  84. ZHANG L, Li Y, Wang J, Hong C, et al
    RNA Modification Signature of Peripheral Blood as a Potential Diagnostic Marker for Pulmonary Hypertension.
    Hypertension. 2022 Jan 11:HYPERTENSIONAHA12118724.
    PubMed    


  85. DIAMANTI E, Karava V, Yerly P, Aubert JD, et al
    Carbon Monoxide Diffusion Capacity as a Severity Marker in Pulmonary Hypertension.
    J Clin Med. 2021;11.
    PubMed    
    Abstract available

  86. HTET M, Nally JE, Martin PE, Dempsie Y, et al
    New Insights into Pulmonary Hypertension: A Role for Connexin-Mediated Signalling.
    Int J Mol Sci. 2021;23.
    PubMed    
    Abstract available

  87. CARRILLO-ROCHA DL, Roldan-Valadez E, Cueto-Robledo G, Garcia-Cesar M, et al
    Review of the myelodysplastic syndrome as a cause of group V pulmonary arterial hypertension: an orphan disease in an orphan pulmonary hypertension group.
    Curr Probl Cardiol. 2022 Jan 7:101110. doi: 10.1016/j.cpcardiol.2022.101110.
    PubMed    
    Abstract available

  88. LEMAY SE, Bonnet S, Potus F
    Commentary on: Xbp1s-Ddit3, DNA damage and pulmonary hypertension.
    Clin Sci (Lond). 2022;136:163-166.
    PubMed    
    Abstract available

  89. FAROOQ O, Jan A, Ghani U, Qazi U, et al
    Pulmonary Hypertension as a Predictor of Early Outcomes of Mitral Valve Replacement: A Study in Rheumatic Heart Disease Patients.
    Cureus. 2021;13:e20070.
    PubMed    
    Abstract available

  90. ZAGORSKI J, Neto-Neves E, Alves NJ, Fisher AJ, et al
    Modulation of soluble guanylate cyclase ameliorates pulmonary hypertension in a rat model of chronic thromboembolic pulmonary hypertension by stimulating angiogenesis.
    Physiol Rep. 2022;10:e15156.
    PubMed    
    Abstract available

  91. DODSON MW, Cirulis MM, Li H, Yue Z, et al
    Frequency of Thrombotic Risk Factors in Patients with Chronic Thromboembolic Pulmonary Hypertension and Acute Pulmonary Embolism: A Case-Control Study.
    Clin Appl Thromb Hemost. 2022;28:10760296211073277.
    PubMed    
    Abstract available

  92. BALIK M, Rulisek J, Flaksa M, Porizka M, et al
    A patient with pulmonary hypertension waiting for donor lungs during the pandemic: 194 days on extracorporeal life support including 143 days on pulmonary artery to left atrium shunt.
    Am J Transplant. 2022 Jan 9. doi: 10.1111/ajt.16949.
    PubMed    
    Abstract available

  93. MARON BJ, Maron MS, Maurer MS, Rowin EJ, et al
    Cardiovascular Diseases That Have Emerged From the Darkness.
    J Am Heart Assoc. 2021;10:e021095.
    PubMed    
    Abstract available

  94. HAYASHI T
    [Proteinase-activated Receptor 1 and 2 under Hypoxic Stress].
    Yakugaku Zasshi. 2021;141:1195-1204.
    PubMed    
    Abstract available

  95. COOK CM, Simpson SQ, Satterwhite L
    Excipient-Induced Pulmonary Vascular Disease: An Underrecognized and Deadly Complication of Opioid Addiction.
    Lung. 2021;199:363-368.
    PubMed    
    Abstract available

  96. ARVANITAKI A, Giannakoulas G, Triantafyllidou E, Pagkopoulou E, et al
    Nailfold videocapillaroscopic changes in patients with pulmonary arterial hypertension associated with connective tissue diseases.
    Rheumatol Int. 2021;41:1289-1298.
    PubMed    
    Abstract available

  97. KOWALSKI J, Deng L, Suennen C, Koca D, et al
    Eplerenone Improves Pulmonary Vascular Remodeling and Hypertension by Inhibition of the Mineralocorticoid Receptor in Endothelial Cells.
    Hypertension. 2021 May 10:HYPERTENSIONAHA12016196.
    PubMed    
    Abstract available

  98. ISHIKAWA T, Sasaki R, Matsuda T, Saeki I, et al
    Successful Management with Dual Therapy of Lenvatinib and Macitentan for Hepatocellular Carcinoma with Portopulmonary Hypertension.
    Hepatology. 2021 Apr 26. doi: 10.1002/hep.31865.
    PubMed    
    Abstract available

  99. LIAO J, Lu W, Chen Y, Duan X, et al
    Upregulation of Piezo1 (Piezo Type Mechanosensitive Ion Channel Component 1) Enhances the Intracellular Free Calcium in Pulmonary Arterial Smooth Muscle Cells From Idiopathic Pulmonary Arterial Hypertension Patients.
    Hypertension. 2021 Apr 5:HYPERTENSIONAHA12016629.
    PubMed    
    Abstract available

  100. LUO F, Wu L, Xie G, Gao F, et al
    Dual-Functional MN-08 Attenuated Pulmonary Arterial Hypertension Through Vasodilation and Inhibition of Pulmonary Arterial Remodeling.
    Hypertension. 2021 Mar 29:HYPERTENSIONAHA12015994.
    PubMed    
    Abstract available

  101. YOSHIFUJI H, Kagebayashi S, Kinoshita H, Fujii T, et al
    A case of pulmonary arterial hypertension complicated by anti-neutrophil cytoplasmic antibody-associated vasculitis and systemic sclerosis.
    Immunol Med. 2021;44:263-269.
    PubMed    
    Abstract available

  102. NUNDLALL N, Playford D, Davis TME, Davis WA, et al
    Relative incidence and predictors of pulmonary arterial hypertension complicating type 2 diabetes: The Fremantle Diabetes Study Phase I.
    J Diabetes Complications. 2020 Oct 27:107773.
    PubMed    
    Abstract available

  103. CAO L, Yao Y, Yang J
    A successful case of heart transplantation concurrent with pulmonary thromboendarterectomy.
    Perfusion. 2021;36:879-882.
    PubMed    
    Abstract available

  104. QIN Y, Zhu B, Li L, Wang D, et al
    Overexpressed lncRNA AC068039.4 Contributes to Proliferation and Cell Cycle Progression of Pulmonary Artery Smooth Muscle Cells Via Sponging miR-26a-5p/TRPC6 in Hypoxic Pulmonary Arterial Hypertension.
    Shock. 2021;55:244-255.
    PubMed    
    Abstract available

  105. ANGELIS D, Savani R, Chalak L
    Nitric oxide and the brain. Part 1: Mechanisms of regulation, transport and effects on the developing brain.
    Pediatr Res. 2021;89:738-745.
    PubMed    
    Abstract available

  106. SLOT E, von der Thusen JH, van Heijst A, van Marion R, et al
    Fast detection of FOXF1 variants in patients with alveolar capillary dysplasia with misalignment of pulmonary veins using targeted sequencing.
    Pediatr Res. 2021;89:518-525.
    PubMed    
    Abstract available

  107. ROSENZWEIG EB, Bates A, Mullen MP, Abman SH, et al
    Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension.
    Ann Am Thorac Soc. 2022 Jan 20. doi: 10.1513/AnnalsATS.202108.
    PubMed    
    Abstract available

  108. JIN BW, Zhang GC, Shen QS, Long K, et al
    [Efficacy and safety of percutaneous transluminal pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50:49-54.
    PubMed    
    Abstract available

  109. ZHANG J, Lu WD, Li M, Li G, et al
    [Risk factors of perinatal complications in patients with pulmonary hypertension underwent cesarean section in 4 Chinese centers].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50:43-48.
    PubMed    
    Abstract available

  110. TANG Y, Zhang HF, Li XL
    [Advances on the diagnosis and treatment of pulmonary hypertension due to left heart disease].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50:8-13.
    PubMed    


  111. HU S, Zhao Y, Qiu C, Li Y, et al
    RAS protein activator like 2 promotes the proliferation and migration of pulmonary artery smooth muscle cell through AKT/mammalian target of Rapamycin complex 1 pathway in pulmonary hypertension.
    Bioengineered. 2022 Jan 19. doi: 10.1080/21655979.2021.1997879.
    PubMed    
    Abstract available

  112. WORKU B, Mack C, Gambardella I
    Bilateral lung transplant for pulmonary hypertension with pulmonary artery aneurysm.
    J Card Surg. 2022 Jan 18. doi: 10.1111/jocs.16233.
    PubMed    


  113. BUSH DS, Ivy DD
    Pulmonary Hypertension in the Population with Down Syndrome.
    Cardiol Ther. 2022 Jan 16. pii: 10.1007/s40119-021-00251.
    PubMed    
    Abstract available

  114. BARTOLO MA, Qureshi MU, Colebank MJ, Chesler NC, et al
    Numerical predictions of shear stress and cyclic stretch in pulmonary hypertension due to left heart failure.
    Biomech Model Mechanobiol. 2022 Jan 17. pii: 10.1007/s10237-021-01538.
    PubMed    
    Abstract available

  115. SONI M, Joshi PK, Patel SC, Shreya D, et al
    Persistent Pulmonary Hypertension: A Look Into the Future Therapy.
    Cureus. 2021;13:e20377.
    PubMed    
    Abstract available

  116. KOVACS G, Olschewski H
    The definition of pulmonary hypertension: history, practical implications and current controversies.
    Breathe (Sheff). 2021;17:210076.
    PubMed    
    Abstract available

  117. MASSON B, Montani D, Humbert M, Capuano V, et al
    Role of Store-Operated Ca(2+) Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension.
    Biomolecules. 2021;11.
    PubMed    
    Abstract available

  118. CORREA RA, Gelape CL, Castro-Bernardes R
    Getting expertise in pulmonary thromboendarterectomy: we always need to move forward!
    J Bras Pneumol. 2021;47:e20210427.
    PubMed    


  119. ABD-ELMONIEM KZ, Yassine IA, Metwalli NS, Hamimi A, et al
    Direct pixel to pixel principal strain mapping from tagging MRI using end to end deep convolutional neural network (DeepStrain).
    Sci Rep. 2021;11:23021.
    PubMed    
    Abstract available

  120. CHENG S, Li VW, So EK, Cheung YF, et al
    Right Ventricular-Pulmonary Arterial Coupling in Repaired Tetralogy of Fallot.
    Pediatr Cardiol. 2022;43:207-217.
    PubMed    
    Abstract available

  121. BAYKAN A, Bilici M, Narin N, Erdem A, et al
    Percutaneous Closure of Atrial Septal Defects with the MemoPart Atrial Septal Occluder: The Early-Term Results of a Multicenter Study.
    Pediatr Cardiol. 2022;43:39-44.
    PubMed    
    Abstract available

  122. HENRIQUES C, Lai A, Andrade H, Pina R, et al
    A rare case of pulmonary lymphangiectasia associated with CHD.
    Cardiol Young. 2022;32:132-134.
    PubMed    
    Abstract available

  123. NETO-NEVES EM, Sousa-Santos O, Ferraz KC, Portella RL, et al
    Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism.
    Nitric Oxide. 2021;115:23-29.
    PubMed    
    Abstract available

  124. MANOR J, Dinu D, Azamian MS, Bi W, et al
    A rare description of pure partial trisomy of 16q12.2q24.3 and review of the literature.
    Am J Med Genet A. 2021;185:2903-2912.
    PubMed    
    Abstract available

  125. CALDERON-GERSTEIN W, Bruno-Huaman A, Damian-Mucha M, Huayllani-Flores L, et al
    Predictive capacity of the brain natriuretic peptide in the screening of heart failure in a high altitude population.
    Respir Physiol Neurobiol. 2021;289:103654.
    PubMed    
    Abstract available

  126. ZARATE YA, Bosanko KA, Thomas MA, Miller DT, et al
    Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2.
    Clin Genet. 2021;99:547-557.
    PubMed    
    Abstract available

  127. JOYE R, Lador F, Aggoun Y, Farhat N, et al
    Outcome of paediatric portopulmonary hypertension in the modern management era: A case report of 6 patients.
    J Hepatol. 2021;74:742-747.
    PubMed    
    Abstract available

  128. WANG Y, Gharahi H, Grobbel MR, Rao A, et al
    Potential damage in pulmonary arterial hypertension: An experimental study of pressure-induced damage of pulmonary artery.
    J Biomed Mater Res A. 2021;109:579-589.
    PubMed    
    Abstract available

  129. JIA Q, Hu Z, Song N, Mao W, et al
    Flavopiridol Mitigates the Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Targeting Cyclin-Dependent Kinase 9.
    Cardiovasc Drugs Ther. 2022 Jan 28. pii: 10.1007/s10557-021-07285.
    PubMed    
    Abstract available

  130. DWIVEDI K, Condliffe R, Sharkey M, Lewis R, et al
    Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease.
    ERJ Open Res. 2022;8.
    PubMed    
    Abstract available

  131. SHEIKH AB, Nasrullah A, Lopez ED, Tanveer Ud Din M, et al
    Sickle Cell Disease-Induced Pulmonary Hypertension: A Review of Pathophysiology, Management, and Current Literature.
    Pulse (Basel). 2021;9.
    PubMed    
    Abstract available

  132. CANNON JE, Jenkins DP, Hoole SP
    Chronic thromboembolic pulmonary hypertension: a review of risk factors, management and current challenges.
    Expert Rev Cardiovasc Ther. 2022 Jan 26. doi: 10.1080/14779072.2022.2034499.
    PubMed    
    Abstract available

  133. MELZIG C, Do TD, Egenlauf B, Fink MA, et al
    Utility of Automated Cardiac Chamber Volumetry by Non-Gated CT Pulmonary Angiography for Detection of Pulmonary Hypertension Using the 2018 Updated Hemodynamic Definition.
    AJR Am J Roentgenol. 2022 Jan 26. doi: 10.2214/AJR.21.27147.
    PubMed    
    Abstract available

  134. NEUMANN M, Wong KA, Lazo K, Stover D, et al
    Iron therapy as a novel treatment of scleroderma-related pulmonary hypertension: A case report and literature review.
    Respirol Case Rep. 2022;10:e0904.
    PubMed    
    Abstract available

  135. SAUNDERS H, Helgeson SA, Abdelrahim A, Rottman-Pietrzak K, et al
    Comparing Diagnosis and Treatment of Pulmonary Hypertension Patients at a Pulmonary Hypertension Center versus Community Centers.
    Diseases. 2022;10.
    PubMed    
    Abstract available

  136. MAEBA T
    Tricuspid valve chordal rupture in a dog with pulmonary hypertension.
    Open Vet J. 2021;11:525-529.
    PubMed    
    Abstract available

  137. KAEMMERER AS, Gorenflo M, Huscher D, Pittrow D, et al
    Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD Registry.
    Cardiovasc Diagn Ther. 2021;11:1255-1268.
    PubMed    
    Abstract available

  138. SATO R, Ishigaki M, Ito H, Mitsushita N, et al
    Progression of left ventricular apical hypoplasia-like restrictive cardiomyopathy with severe pulmonary hypertension: Follow-up from fetal stage.
    J Cardiol Cases. 2021;24:161-164.
    PubMed    
    Abstract available

  139. ARARUNA LVM, de Oliveira DC, Pereira MC, Moura Neto A, et al
    Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients.
    Front Endocrinol (Lausanne). 2022;12:780397.
    PubMed    
    Abstract available

  140. RAHAYUNINGSIH SE, Kuswiyanto RB, Rayani P, Wijaya EA, et al
    Low serum 25-hydroxyvitamin D (vitamin D) level among children with ventricular septal defect: how big is the risk for pulmonary hypertension?
    Cardiol Young. 2022 Jan 24:1-5. doi: 10.1017/S1047951122000051.
    PubMed    
    Abstract available

  141. OSMAN B, Bou Akel I, Tulimat T, Sfeir P, et al
    Initiating a Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Endarterectomy Program Based on a Single Center Experience in Lebanon.
    Semin Cardiothorac Vasc Anesth. 2022 Jan 22:10892532211066645.
    PubMed    
    Abstract available

  142. FENG X, Wang K, Yang T, Liu Y, et al
    LncRNA-GAS5/miR-382-3p axis inhibits pulmonary artery remodeling and promotes autophagy in chronic thromboembolic pulmonary hypertension.
    Genes Genomics. 2022 Jan 23. pii: 10.1007/s13258-021-01202.
    PubMed    
    Abstract available

  143. KAMADA H, Ota H, Nakamura M, Sun W, et al
    Quantification of vortex flow in pulmonary arteries of patients with chronic thromboembolic pulmonary hypertension.
    Eur J Radiol. 2022;148:110142.
    PubMed    
    Abstract available

  144. DILASSER F, Rio M, Rose L, Tesse A, et al
    Smooth muscle Rac1 contributes to pulmonary hypertension.
    Br J Pharmacol. 2022 Jan 21. doi: 10.1111/bph.15805.
    PubMed    
    Abstract available

  145. ROYCHOUDHURY A, Rahman A, Harhay MO
    Survival by Lung-Transplantation Preference in Interstitial Lung Disease Patients with Severe Pulmonary Hypertension and High Lung Allocation Score.
    Lung. 2022 Jan 22. pii: 10.1007/s00408-021-00504.
    PubMed    


  146. JENTZER JC, Wiley BM, Reddy YNV, Barnett C, et al
    Epidemiology and outcomes of pulmonary hypertension in the cardiac intensive care unit.
    Eur Heart J Acute Cardiovasc Care. 2022 Jan 22. pii: 6513783.
    PubMed    
    Abstract available

  147. NAKANO M, Koga M, Hashimoto T, Matsushita N, et al
    Right ventricular overloading is attenuated in monocrotaline-induced pulmonary hypertension model rats with a disrupted Gpr143 gene, the gene that encodes the 3,4-l-dihydroxyphenyalanine (l-DOPA) receptor.
    J Pharmacol Sci. 2022;148:214-220.
    PubMed    
    Abstract available

  148. OH S, Kim JH, Cho KH, Kim MC, et al
    Clinical impact of pulmonary hypertension on the outcomes of acute myocardial infarction patients with or without chronic obstructive pulmonary disease.
    Medicine (Baltimore). 2022;101:e28627.
    PubMed    
    Abstract available

  149. GARCIA AD, Liu W, Agarwal H, Hanna WJ, et al
    Dead space ratio as a tool in nitric oxide weaning: a study in pulmonary hypertensive disease - CORRIGENDUM.
    Cardiol Young. 2022 Jan 21:1. doi: 10.1017/S1047951122000075.
    PubMed    


  150. MEIJERINK F, de Witte SM, Limpens J, de Winter RJ, et al
    Prognostic Value of Pulmonary Hypertension, Right Ventricular Function and Tricuspid Regurgitation on Mortality After Transcatheter Mitral Valve Repair: A Systematic Review and Meta-Analysis.
    Heart Lung Circ. 2022 Jan 17. pii: S1443-9506(21)01401.
    PubMed    
    Abstract available

  151. BANASZKIEWICZ M, Gasecka A, Darocha S, Florczyk M, et al
    Circulating Blood-Based Biomarkers in Pulmonary Hypertension.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  152. LAGGNER M, Hacker P, Oberndorfer F, Bauer J, et al
    The Roles of S100A4 and the EGF/EGFR Signaling Axis in Pulmonary Hypertension with Right Ventricular Hypertrophy.
    Biology (Basel). 2022;11.
    PubMed    
    Abstract available

  153. WANG MJ, Tang YY, Yu ZX
    [Research progress on the role of gas signal molecules on pulmonary arterial hypertension].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50:14-19.
    PubMed    


  154. YOSHIMURA D, Uemura M, Haraguchi N, Paku M, et al
    [Laparoscopic Left Hemicolectomy for Advanced Descending Colon Cancer in Patient with Idiopathic Pulmonary Arterial Hypertension-Report of a Case].
    Gan To Kagaku Ryoho. 2021;48:1984-1986.
    PubMed    
    Abstract available

  155. HU Y, Wei Z, Zhang C, Lu C, et al
    The effect of levosimendan on right ventricular function in patients with heart dysfunction: a systematic review and meta-analysis.
    Sci Rep. 2021;11:24097.
    PubMed    
    Abstract available

  156. EWERT R, Habedank D, Halank M, Stubbe B, et al
    Strategies for optimizing intravenous prostacyclin-analog therapy in patients with pulmonary arterial hypertension.
    Expert Rev Respir Med. 2022;16:57-66.
    PubMed    
    Abstract available

  157. GUO FX, Zhu XC, Hu X, Chu DJ, et al
    The treatment of acute exacerbation of chronic obstructive pulmonary disease complicated by pulmonary arterial hypertension.
    Asian J Surg. 2022;45:590-591.
    PubMed    


  158. TAKEUCHI K, Goda A, Ito J, Kikuchi H, et al
    Successful epoprostenol withdrawal and termination with an aid of the exercise stress test in pulmonary arterial hypertension.
    Int J Cardiol. 2022;346:80-85.
    PubMed    
    Abstract available

  159. JIAN J, Xia L
    miR-1226-3p Promotes eNOS Expression of Pulmonary Arterial Endothelial Cells to Mitigate Hypertension in Rats via Targeting Profilin-1.
    Biomed Res Int. 2021;2021:1724722.
    PubMed    
    Abstract available

  160. VAKHRUSHEV AD, capital ES, Cyrillicondori Leonardo HI, Goncharova NS, Korobchenko LE, et al
    Pulmonary and Systemic Hemodynamics following Multielectrode Radiofrequency Catheter Renal Denervation in Acutely Induced Pulmonary Arterial Hypertension in Swine.
    Biomed Res Int. 2021;2021:4248111.
    PubMed    
    Abstract available

  161. ZOU HX, Qiu BQ, Lai SQ, Zhou XL, et al
    Iron Metabolism and Idiopathic Pulmonary Arterial Hypertension: New Insights from Bioinformatic Analysis.
    Biomed Res Int. 2021;2021:5669412.
    PubMed    
    Abstract available

  162. NAKAGAWA A, Yasumura Y, Yoshida C, Okumura T, et al
    Prognostic Importance of Pulmonary Arterial Capacitance in Acute Decompensated Heart Failure With Preserved Ejection Fraction.
    J Am Heart Assoc. 2021;10:e023043.
    PubMed    
    Abstract available

  163. SUN S, Kong Q, Cai Z, Wang M, et al
    circGrm1 promotes pulmonary artery smooth muscle cell proliferation and migration via suppression of GRM1 expression by FUS.
    Int J Mol Med. 2021;48.
    PubMed    
    Abstract available

  164. KRAMER T, Wissmuller M, Natsina K, Gerhardt F, et al
    Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long-term study.
    J Cachexia Sarcopenia Muscle. 2021;12:1501-1512.
    PubMed    
    Abstract available

  165. HAREL F, Nguyen QT, Nsaibia MJ, Finnerty V, et al
    SPECT imaging of pulmonary vascular disease in bleomycin-induced lung fibrosis using a vascular endothelium tracer.
    Respir Res. 2021;22:240.
    PubMed    
    Abstract available

  166. LI F, Wang D, Wang H, Chen L, et al
    Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a.
    Respir Res. 2021;22:239.
    PubMed    
    Abstract available

  167. TURCK P, Salvador IS, Campos-Carraro C, Ortiz V, et al
    Blueberry extract improves redox balance and functional parameters in the right ventricle from rats with pulmonary arterial hypertension.
    Eur J Nutr. 2022;61:373-386.
    PubMed    
    Abstract available

  168. PATRO M, Gothi D, Vaidya S
    A young lady with dyspnoea: Quest for the cause.
    Monaldi Arch Chest Dis. 2021;91.
    PubMed    
    Abstract available

  169. LV Y, Ma P, Wang J, Xu Q, et al
    Betaine alleviates right ventricular failure via regulation of Rho A/ROCK signaling pathway in rats with pulmonary arterial hypertension.
    Eur J Pharmacol. 2021 Jul 7:174311. doi: 10.1016/j.ejphar.2021.174311.
    PubMed    
    Abstract available

  170. BARTOLUCCI R, Dosne AG, Csonka D, Perez-Ruixo JJ, et al
    A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial Hypertension.
    Clin Pharmacokinet. 2021;60:1605-1619.
    PubMed    
    Abstract available

  171. DA COSTA ADAO RM, Archer SL
    Scientist on the Spot: Exploring the cause and cure for pulmonary arterial hypertension.
    Cardiovasc Res. 2021;117:e82-e83.
    PubMed    


  172. SEKAR D
    Extracellular vesicles are involved in oxidative stress and mitochondrial homeostasis in pulmonary arterial hypertension.
    Hypertens Res. 2021;44:1028-1029.
    PubMed    


  173. CORSSAC GB, Bonetto JP, Campos-Carraro C, Cechinel LR, et al
    Pulmonary arterial hypertension induces the release of circulating extracellular vesicles with oxidative content and alters redox and mitochondrial homeostasis in the brains of rats.
    Hypertens Res. 2021;44:918-931.
    PubMed    
    Abstract available

  174. MANDRAS S, Kovacs G, Olschewski H, Broderick M, et al
    Combination Therapy in Pulmonary Arterial Hypertension-Targeting the Nitric Oxide and Prostacyclin Pathways.
    J Cardiovasc Pharmacol Ther. 2021;26:453-462.
    PubMed    
    Abstract available

  175. SZAFRANSKI P, Gambin T, Karolak JA, Popek E, et al
    Lung-specific distant enhancer cis regulates expression of FOXF1 and lncRNA FENDRR.
    Hum Mutat. 2021;42:694-698.
    PubMed    
    Abstract available

  176. THACKERAY JT
    The right stuff? Imaging cardiac sympathetic neuronal integrity of the right ventricle in pulmonary arterial hypertension.
    J Nucl Cardiol. 2021;28:423-426.
    PubMed    


  177. ZELT JGE, Schock S, deKemp RA, Stewart DJ, et al
    [(11)C]meta-hydroxyephedrine PET evaluation in experimental pulmonary arterial hypertension: Effects of carvedilol of right ventricular sympathetic function.
    J Nucl Cardiol. 2021 Jan 26. pii: 10.1007/s12350-020-02494.
    PubMed    
    Abstract available

  178. SARINC ULASLI S, Koksal D, Karcioglu O, Armagan B, et al
    Pulmonary manifestations of antiphospholipid syndrome: a retrospective analysis of 67 patients.
    J Thromb Thrombolysis. 2021;52:640-645.
    PubMed    
    Abstract available

  179. BUDNIOK T, ElSayed Y, Louis D
    Effect of Vasopressin on Systemic and Pulmonary Hemodynamics in Neonates.
    Am J Perinatol. 2021;38:1330-1334.
    PubMed    
    Abstract available

  180. DEFERM S, Bertrand PB, Yucel E, Bernard S, et al
    Impact of Pulmonary Hypertension on Outcomes in Patients With Mitral Annular Calcium and Associated Mitral Valve Dysfunction.
    Am J Cardiol. 2022 Jan 3. pii: S0002-9149(21)01198.
    PubMed    
    Abstract available

  181. ZHOU Y, Liu L, Fan F, Ma W, et al
    Echocardiographic Estimated Pulmonary Systolic Pressure and Outcome After Noncardiac-Obstetrics Surgery in Postcapillary Pulmonary Hypertensive Patients.
    Am J Cardiol. 2022 Jan 20. pii: S0002-9149(21)01284.
    PubMed    
    Abstract available

  182. NACI B, Demir R, Onder OO, Sinan UY, et al
    Effects of Adding Respiratory Training to Osteopathic Manipulative Treatment on Exhaled Nitric Oxide Level and Cardiopulmonary Function in Patients With Pulmonary Arterial Hypertension.
    Am J Cardiol. 2021 Oct 24. pii: S0002-9149(21)00946.
    PubMed    
    Abstract available

  183. MARVIN-PEEK J, Hemnes A, Huang S, Silverman-Loyd L, et al
    Daily Step Counts Are Associated with Hospitalization Risk in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;204:1338-1340.
    PubMed    


  184. LAPATRA T, Baird GL, Goodman R, Pinder D, et al
    Remote Six-Minute Walk Testing in Patients with Pulmonary Hypertension: A Pilot Study.
    Am J Respir Crit Care Med. 2022 Jan 11. doi: 10.1164/rccm.202110-2421.
    PubMed    


  185. MANZ XD, Szulcek R, Pan X, Symersky P, et al
    Epigenetic Modification of the VWF Promotor Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Jan 26. doi: 10.1164/rccm.202109-2075.
    PubMed    
    Abstract available

  186. BEHR J
    Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally.
    Am J Respir Crit Care Med. 2022;205:144-145.
    PubMed    


  187. MOUTSOGLOU DM
    2021 American Thoracic Society BEAR Cage Winning Proposal: Microbiome Transplant in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;205:13-16.
    PubMed    


  188. JIN Q, Guan L, Pan W, Zhou D, et al
    Initial Triple Combination Therapy for Intermediate-and High-Risk Pulmonary Arterial Hypertension: Standard of Care or Still Too Soon to Tell?
    Am J Respir Crit Care Med. 2021;204:1491-1492.
    PubMed    


  189. RAHAGHI FN, Trieu M, Shaikh F, Abtin F, et al
    Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;204:1478-1481.
    PubMed    


  190. DIEFFENBACH PB, Mallarino Haeger C, Rehman R, Corcoran AM, et al
    A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature.
    Am J Respir Crit Care Med. 2021;204:1433-1451.
    PubMed    
    Abstract available

  191. ROGERS E, Moffet EW, Allen N, Rivera-Zengotita M, et al
    A 60-Year-Old Man With Dyspnea, Proximal Muscle Weakness, and Pulmonary Arterial Hypertension.
    Chest. 2021;160:e225-e231.
    PubMed    
    Abstract available

  192. QURESHI R, Vayntrub Y, Aswad B, Choudhary G, et al
    Dyspnea, Elevated Jugular Venous Pulse, and Lower Extremity Edema in the Setting of Interstitial Lung Disease in a Patient Who Has Undergone Liver and Kidney Transplantation.
    Chest. 2021;160:e295-e298.
    PubMed    
    Abstract available

  193. HEMNES AR, Silverman-Lloyd LG, Huang S, MacKinnon G, et al
    A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension.
    Chest. 2021;160:1042-1052.
    PubMed    
    Abstract available

  194. GOEL K, Maleki-Fischbach M, George MP, Kim D, et al
    A 56-Year-Old Man With Emphysema, Rash, and Arthralgia.
    Chest. 2021;160:e513-e518.
    PubMed    
    Abstract available

  195. FAKILI F, Duzen IV, Kaplan M, Bayram NG, et al
    A 24-Year-Old Woman With Dyspnea, Chest Pain, and Dry Cough.
    Chest. 2021;160:e503-e506.
    PubMed    
    Abstract available

  196. GOEL K, Hon SM, Farber HW, George MP, et al
    Pulmonary Arterial Hypertension: What Rare Diseases Tell Us About Disparities in Disease Registries, Clinical Trials, and Treatment Algorithms.
    Chest. 2021;160:1981-1983.
    PubMed    


  197. DUVVURI PD, Bhardwaj C, Wattanakit K
    A 50-Year-Old Woman With Shortness of Breath.
    Chest. 2021;160:e365-e368.
    PubMed    


  198. TAKAHASHI T, Terada Y, Pasque MK, Liu J, et al
    Clinical features and outcomes of combined pulmonary fibrosis and emphysema after lung transplantation.
    Chest. 2021 Jun 26. pii: S0012-3692(21)01264-2. doi: 10.1016/j.chest.2021.
    PubMed    
    Abstract available

  199. SWEATT AJ, Miyagawa K, Rhodes CJ, Taylor S, et al
    Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency.
    Chest. 2021;160:1442-1458.
    PubMed    
    Abstract available

  200. KERR KM, Elliott CG, Chin K, Benza RL, et al
    Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-up.
    Chest. 2021;160:1822-1831.
    PubMed    
    Abstract available

  201. MARCIANO BE, Olivier KN, Folio LR, Zerbe CS, et al
    Pulmonary Manifestations of GATA2 Deficiency.
    Chest. 2021;160:1350-1359.
    PubMed    
    Abstract available

  202. LEE MH, Doran J, Bang TJ, Hohsfield R, et al
    Pulmonary Arterial Hypertension and Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Novel Association?
    Chest. 2021;160:2260-2265.
    PubMed    


  203. RAHAGHI FN, Nardelli P, Harder E, Singh I, et al
    Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging.
    Chest. 2021;160:2220-2231.
    PubMed    
    Abstract available

  204. MONTEIRO JP, Rodor J, Caudrillier A, Scanlon JP, et al
    MIR503HG Loss Promotes Endothelial-to-Mesenchymal Transition in Vascular Disease.
    Circ Res. 2021;128:1173-1190.
    PubMed    
    Abstract available

  205. FUJIWARA T, Takeda N, Hara H, Ishii S, et al
    Three-Dimensional Visualization of Hypoxia-Induced Pulmonary Vascular Remodeling in Mice.
    Circulation. 2021;144:1452-1455.
    PubMed    


  206. BISSERIER M, Mathiyalagan P, Zhang S, Elmastour F, et al
    Regulation of The Methylation and Expression Levels of the BMPR2 Gene by SIN3a As A Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.
    Circulation. 2021 Jun 3. doi: 10.1161/CIRCULATIONAHA.120.047978.
    PubMed    
    Abstract available

  207. COUTINHO E SILVA RDS, Wiggenhauser LM, Simas R, Zanoni FL, et al
    Thoracic bilateral sympathectomy attenuates oxidative stress and prevents ventricular remodelling in experimental pulmonary hypertension.
    Eur J Cardiothorac Surg. 2021 Dec 27. pii: 6484479. doi: 10.1093.
    PubMed    
    Abstract available

  208. D'ALTO M, Di Maio M, Romeo E, Argiento P, et al
    Echocardiographic probability of pulmonary hypertension: a validation study.
    Eur Respir J. 2022 Jan 7. pii: 13993003.02548-2021.
    PubMed    
    Abstract available

  209. BRAAMS NJ, Boon GJAM, de Man FS, van Es J, et al
    Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2021;58.
    PubMed    
    Abstract available

  210. KREMER N, Rako Z, Douschan P, Gall H, et al
    Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension.
    J Heart Lung Transplant. 2021 Dec 5. pii: S1053-2498(21)02616.
    PubMed    
    Abstract available

  211. KIM NH, Hemnes AR, Chakinala MM, Highland KB, et al
    Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE.
    J Heart Lung Transplant. 2021;40:279-288.
    PubMed    
    Abstract available

  212. MENDEZ A, Codsi E, Gonzalez Barlatay F, Lapointe A, et al
    Pulmonary hypertension associated with vein of Galen malformation. Fetal cardiac hemodynamic findings and physiological considerations.
    J Perinatol. 2022 Jan 12. pii: 10.1038/s41372-021-01297.
    PubMed    
    Abstract available

  213. JAIN A, Giesinger RE, Dakshinamurti S, ElSayed Y, et al
    Care of the critically ill neonate with hypoxemic respiratory failure and acute pulmonary hypertension: framework for practice based on consensus opinion of neonatal hemodynamics working group.
    J Perinatol. 2022 Jan 11. pii: 10.1038/s41372-021-01296.
    PubMed    
    Abstract available

  214. HASSOUN PM
    Pulmonary Arterial Hypertension.
    N Engl J Med. 2021;385:2361-2376.
    PubMed    


  215. GANAPATHI AM, Daniels CJ
    Pulmonary-Artery Aneurysm with Acute Dissection.
    N Engl J Med. 2022;386:273.
    PubMed    


  216. SWIFT AJ, Wilson F, Cogliano M, Kendall L, et al
    Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study.
    Thorax. 2021;76:1032-1035.
    PubMed    
    Abstract available

  217. PERRODIN SF, Vogt AP, Berzigotti A, Kim-Fuchs C, et al
    Resolution of Precapillary Pulmonary Hypertension After Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Systematic Review and Case Report.
    Transplant Proc. 2021 Dec 30. pii: S0041-1345(21)00875.
    PubMed    
    Abstract available

  218. JOKI Y, Konishi H, Ebinuma H, Takasu K, et al
    Circulating sLR11 levels predict severity of pulmonary hypertension due to left heart disease.
    PLoS One. 2021;16:e0261753.
    PubMed    
    Abstract available

  219. ASANO R, Ogo T, Morita Y, Kotoku A, et al
    Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension.
    PLoS One. 2021;16:e0260456.
    PubMed    
    Abstract available

  220. DENG H, Xu Y, Hu X, Zhuang ZW, et al
    MEKK3-TGFbeta crosstalk regulates inward arterial remodeling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;